Park Place Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.2K Hold
143
0.01% 391
2025
Q4
$35.9K Buy
143
+27
+23% +$7.17K 0.01% 375
2025
Q3
$33.3K Hold
116
0.01% 387
2025
Q2
$30.7K Hold
116
0.01% 417
2025
Q1
$27K Hold
116
0.01% 424
2024
Q4
$26.6K Hold
116
0.01% 448
2024
Q3
$25.9K Buy
116
+3
+3% +$659 0.01% 467
2024
Q2
$23K Sell
113
-60
-35% -$12.2K 0.01% 481
2024
Q1
$37.8K Sell
173
-171
-50% -$37.7K 0.01% 444
2023
Q4
$78.2K Sell
344
-51
-13% -$10.7K 0.03% 350
2023
Q3
$79.4K Buy
395
+68
+21% +$14.3K 0.02% 390
2023
Q2
$67.8K Sell
327
-4
-1% -$776 0.02% 435
2023
Q1
$65.2K Buy
331
+11
+3% +$2.26K 0.02% 440
2022
Q4
$65K Buy
+320
New +$62.5K 0.02% 445

Other funds holding LH

Park Place Capital's LH Position: Q1 2026 in Review

Park Place Capital held its Labcorp (LH) position steady in Q1 2026 at 143 shares worth $38.2K. The position accounts for 0.01% of the portfolio, ranked #391.

Park Place Capital first reported a position in LH in Q4 2022 and has held it in 14 quarters since. The position peaked at $79.4K in Q3 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Park Place Capital held 143 shares of Labcorp worth $38.2K as of Q1 2026.
  • Park Place Capital left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up 0.01% of Park Place Capital's portfolio in Q1 2026, its #391 holding.
  • Park Place Capital first reported a position in Labcorp in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's Labcorp position peaked at $79.4K in Q3 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.